ElevateSells LogoElevateSells
Back to Companies Directory
VERIFIED COMPANY DOSSIER

Herantis Pharma Plc.

Verified Intel

Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’s lead product, HER-096 is a first-in-class agent in development for the treatment of Parkinson’s disease with disease modifying potential and convenient subcutaneous administration. Primary objective of the ongoing Phase 1b clinical trial is to assess the safety, tolerability and pharmacokinetics of repeated subcutaneous doses of HER-096; the trial will also evaluate selected biomarkers and monitor symptoms associated with Parkinson’s disease. Topline data from Phase 1b trial is expected in September 2025. The Phase 1b trial is funded by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Parkinson’s Virtual Biotech. Herantis is listed on the Nasdaq First North Growth Market Finland.

herantis.comLinkedIn

Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’s lead product, HER-096 is a first-in-class agent in development for the treatment of Parkinson’s disease with disease modifying potential and convenient subcutaneous administration. Primary objective of the ongoing Phase 1b clinical trial is to assess the safety, tolerability and pharmacokinetics of repeated subcutaneous doses of HER-096; the trial will also evaluate selected biomarkers and monitor symptoms associated with Parkinson’s disease. Topline data from Phase 1b trial is expected in September 2025. The Phase 1b trial is funded by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Parkinson’s Virtual Biotech. Herantis is listed on the Nasdaq First North Growth Market Finland.

Primary SectorGeneral Industry
Workforce Size11-50 Employees
Global HQHelsinki, Finland
Total Capital RaisedBootstrapped / Private

Corporate Firmographics

Entity classification and operating profile

Industry
General
Company Type
Public Company
Founded
2008
Employee Bracket
11-50
Estimated Revenue Range
Undisclosed

Geographic Coordinates

Headquarters address and regional territory

Street Address
Bertel Jungin aukio 1 Southern Finland Espoo
City
Helsinki
Region / State
Uusimaa
Postal Code
02600
Country
Finland

Digital Presence & Footprint

Verified domains, socials, and directory profiles

Official Domainherantis.com
Visit Site
LinkedIn NetworkActive Profile
Open LinkedIn
OUTREACH AUTOMATION

Target Decision-Makers at Herantis Pharma Plc.

Connect your mailboxes, set up your autonomous SDR Agent, and start generating hyper-personalized pipeline for accounts like Herantis Pharma Plc. in minutes.

SYNTHESIZED INTEL

Frequently Asked Questions

Verified business inquiries and firmographic telemetry for Herantis Pharma Plc..